(Report) 46th Breakfast Meeting
date : 12/12/2013
On the 12th December 2013 (Thursday), Health and Global Policy Institute hold its 46th Regular Breakfast Meeting.
Japan has maintained the world well-known health insurance system since inauguration of the system in 1961.
However, the current social insurance system is facing a critical turning point, due to a sharp drop in birth rate and change in the disease patterns, and advancement of medicine.
Mean while, Abe administration has proposed the expansion of medicine-related industries and distribution of the most advanced treatment across the nation as one of main pillars of growth strategy.
It is questionable whether Japanese universal public insurance system would be maintained while stimulating advanced medical treatment at the same time. If that was possible, what has been done to reform Japanese health care system?
The executive director of the HGPI, Dr. Toshio Miyata, who has worked as a physician and has experiences in basic research, clinical trial, and health policy-making, shared his view on critical issues in the related field.
■Date and Time
December 12, 2013 8:00-9:00 (Doors open:7:45)
GARB Marunouchi (2-2-3 Marunouchi, Chiyoda-ku, Tokyo)
Toshio Miyata (Executive Director, Health and Global Policy Institute)
Registration deadline: 2013-12-10
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (AMR Alliance Japan, December 22, 2021)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society (July 13, 2022)
- [Announcement] HGPI Declares the Ministry of the Environment-led ‘Deco-Katsu Declaration’ and Participation in the ‘Deco-Katsu’ Supporters (October 16, 2023)
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
[Registration Open] (Webinar) HGPI Cooperation with Lancet Countdown 2023 Japan Presentation “Climate Change as a Children’s Health Issue: The Latest Lancet Report Sounds the Alarm for Health Commitments” (December 14, 2023)
[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) Support Project “Necessary Steps for Promoting PPI in Policy Making” (October 3, 2023)
[Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
[Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)